Details of the Drug Combinations

General Information of This Drug (ID: DMH2NMY)

Drug Name

Mepivacaine DMH2NMY

Synonyms

Carbocaine; Mepivacaina; Mepivacainum; Mepivicaine; Scandicain; Scandicaine; Scandicane; Arestocaine HCL; Carboplyin Dental; Isocaine HCL; Carbocaine (TN); Carboplyin Dental (TN); D-mepivacaine; DL-Mepivacaine; Mepivacaina [INN-Spanish]; Mepivacaine (INN); Mepivacaine [INN:BAN]; Mepivacainum [INN-Latin]; Polocaine (TN); Polocaine-Mpf; S-Ropivacaine Mesylate; D(-)-Mepivacaine; N-Methyl-2-pipecolic acid, 2,6-dimethylanilide; N-Methyl-2-pipecolic acid, 2,6-xylidide; N-Methylhexahydro-2-picolinic acid, 2,6-dimethylanilide; N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide; N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide; (+-)-1-Methyl-2',6'-pipecoloxylidide; 1-METHYL-2',6'-PIPECOLOXYLIDIDE

Indication

Disease Entry	ICD 11	Status	REF
Analgesia	MB40.8	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Anesthetics

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Dexamethasone + Mepivacaine	DCZG6E3	Dexamethasone	Anesthesia	[2]
Mepivacaine + Ropivacaine	DCV8XJN	Ropivacaine	Local Anesthetic	[3]
Articaine + Mepivacaine	DC7SUJP	Articaine	Symptomatic Irreversible Pulpitis	[4]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT00802009) Dexamethasone and Analgesic Duration After Supraclavicular Brachial Plexus Blockade
3	ClinicalTrials.gov (NCT00825786) Ultrasound Guided Supraclavicular Nerve Block
4	ClinicalTrials.gov (NCT03725579) Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine